Notice of Proposed Sale · 144/A
MapLight Therapeutics, Inc.
MPLTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144/A
primary_doc.xml
Amendment · This filing reports the amendment as submitted.
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- MapLight Therapeutics, Inc.
- Issuer CIK
- 0001770069
- SEC file number
- 001-42914
- Phone
- (617)-984-6300
- Person for whose account securities are to be sold
- Anatol Kreitzer
- Relationships to issuer
- Officer
- Street
- 800 Chesapeake Drive
- City
- Redwood City
- State / country code
- CA
- Postal code
- 94063
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| MapLight voting common stock | 36,284 | 1,375,526.00 | 42,618,165 | 07/15/2026 | Nasdaq | Morgan Stanley Smith Barney LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| MapLight voting common stock | 07/15/2026 | Restricted stock unit settlement | MapLight Therapeutics, Inc. | 36,284 | N | 07/15/2026 | N/A |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Anatol Kreitzer | MapLight voting common stock | 04/15/2026 | 3,316 | 88,239.00 |
| Anatol Kreitzer | MapLight voting common stock | 04/27/2026 | 45,422 | 1,347,066.00 |
Seller — prior-sale row 1, entry 1
- Name
- Anatol Kreitzer
- Street
- 800 Chesapeake Drive
- City
- Redwood City
- State / country code
- CA
- Postal code
- 94063
Seller — prior-sale row 2, entry 1
- Name
- Anatol Kreitzer
- Street
- 800 Chesapeake Drive
- City
- Redwood City
- State / country code
- CA
- Postal code
- 94063
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
Shares to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit vesting.
Notice signature
- Notice date
- 07/15/2026
- Signed
- /s/ Anatol Kreitzer
Company context
We are a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. We were founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. Our discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. We believe our deep understanding of these causal links between the modulation of defined neural circuits and the resulting changes in disease-specific behaviors will enable us to develop therapeutics that can deliver efficacy, safety, tolerability and ease-of-use advantages to patients and prescribers.